Fenofibrate: here's the fair price
This is what US pharmacies pay, on average, for fenofibrate. Use it to spot a fair cash price, and feel good about asking for one.
Fenofibrate 54 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Fenofibrate 54 Mg Tablet. Pharmacies pay about $2.19 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| FENOFIBRATE 54 MG TABLETGeneric | $0.07 per tablet or capsule | $2.19 | 10/21/2026 |
| FENOFIBRATE 48 MG TABLETGeneric | $0.08 per tablet or capsule | $2.40 | 10/21/2026 |
| FENOFIBRATE 160 MG TABLETGeneric | $0.09 per tablet or capsule | $2.78 | 10/21/2026 |
| FENOFIBRATE 67 MG CAPSULEGeneric | $0.09 per tablet or capsule | $2.80 | 10/21/2026 |
| FENOFIBRATE 145 MG TABLETGeneric | $0.12 per tablet or capsule | $3.57 | 10/21/2026 |
| FENOFIBRATE 134 MG CAPSULEGeneric | $0.12 per tablet or capsule | $3.64 | 10/21/2026 |
| FENOFIBRATE 200 MG CAPSULEGeneric | $0.17 per tablet or capsule | $5.14 | 10/21/2026 |
| FENOFIBRATE 43 MG CAPSULEGeneric | $0.40 per tablet or capsule | $11.86 | 10/21/2026 |
| FENOFIBRATE 130 MG CAPSULEGeneric | $0.72 per tablet or capsule | $21.61 | 10/21/2026 |
| FENOFIBRATE 50 MG CAPSULEGeneric | $2.56 per tablet or capsule | $76.80 | 10/21/2026 |
| FENOFIBRATE 150 MG CAPSULEGeneric | $5.32 per tablet or capsule | $159.54 | 10/21/2026 |
| FENOFIBRATE 40 MG TABLETGeneric | $5.55 per tablet or capsule | $166.46 | 10/21/2026 |
| FENOFIBRATE 120 MG TABLETGeneric | $16.29 per tablet or capsule | $488.75 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Fenofibrate tablet USP is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia ( 1.1 ). For treatment of adult patients with severe hypertriglyceridemia ( 1.2 ). Limitations of Use: Fenofibrate was not shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus ( 5.1 ). 1.1 Primary Hypercholesterolemia or Mixed Dyslipidemia Fenofibrate tablet USP is indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein...
Common side effects (FDA label)
6 ADVERSE REACTIONS The following serious adverse reactions are described below and elsewhere in the labeling: •Mortality and coronary heart disease morbidity [see WARNINGS AND PRECAUTIONS ( 5.1 )] •Hepatoxicity [see WARNINGS AND PRECAUTIONS ( 5.2 )] •Pancreatitis [see WARNINGS AND PRECAUTIONS ( 5.7 )] •Hypersensitivity reactions [see WARNINGS AND PRECAUTIONS ( 5.9 )] • Venothromboembolic disease [see WARNINGS AND PRECAUTIONS ( 5.10 )] Adverse reactions > 2% and at least 1% greater than placebo: Abnormal liver tests, increased AST, increased ALT, increased CPK, and rhinitis ( 6 ). To report...
Drug interactions (from the label)
7 DRUG INTERACTIONS Coumarin anticoagulants: ( 7.1 ). Immunosuppressants: ( 7.2 ). Bile acid resins: ( 7.3 ). 7.1 Coumarin Anticoagulants Potentiation of coumarin-type anticoagulant effects has been observed with prolongation of the PT/INR. Caution should be exercised when coumarin anticoagulants are given in conjunction with fenofibrate. The dosage of the anticoagulants should be reduced to maintain the PT/INR at the desired level to prevent bleeding complications. Frequent PT/INR determinations are advisable until it has been definitely determined that the PT/INR has stabilized [see WARNINGS AND PRECAUTIONS (5.6)] . 7.2 Immunosuppressants Immunosuppressants such as cyclosporine and...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate. Monitor patient's liver function, including serum ALT, AST, and total bilirubin, atbaseline and periodically for the duration of therapy. Discontinue if signs or symptoms of liver injury develop or if elevated enzyme levels persist ( 5.2 ). Myopathy and rhabdomyolysis: Have been reported in patients taking fenofibrate. Risks are increased during co-administration with a statin (with a significantly higher rate observed for gemfibrozil), particularly in elderly patients and patients with diabetes, renal failure, or hypothyroidism ( 5.3...
Source: FDA drug label via openFDA, label effective 2024-04-29. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.